openPR Logo

Press Releases from Cartherics (11 total)

CARTHERICS TO PRESENT AT THE 2025 BIO INTERNATIONAL CONVENTION

• Cartherics' Chief Operating Officer, Dr. Ian Nisbet, will be presenting at BIO on Monday 16th June, 2025 at 1.30pm (US EDT). Melbourne, Australia, 28 May

CARTHERICS RAISES OVER $15 MILLION IN OVERSUBSCRIBED PRIVATE FINANCING ROUND TO …

• Financing round was significantly oversubscribed by existing investors and new private investors. • Funding will enable the Company to progress clinical trials of its lead CAR-NK

CARTHERICS ENTERS AGREEMENTS WITH UNIQUEST, THE UNIVERSITY OF QUEENSLAND AND THE …

• Cartherics, UniQuest and The University of Sydney enter Technology Licence Agreement for Cartherics' iPSC cell line. • Cartherics, The University of Queensland and The University of Sydney

CARTHERICS GRANTED EUROPEAN PATENT FOR MULTIPLE DEVELOPMENT CANDIDATES

Melbourne, Australia, 23 May 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,

CARTHERICS EXECUTES OPTION AGREEMENT WITH THE OHIO STATE UNIVERSITY: TISSUE FACT …

Melbourne, Australia, 20 March 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,

POSITIVE PRE-IND MEETING WITH US FDA FOR NEW OVARIAN CANCER CELL THERAPY

Melbourne, Australia, 1 February 2024 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,

Cartherics appoints new Chief Scientific Officer

Melbourne, Australia, 17 October 2023 - Cartherics Pty Ltd ("Cartherics" or "Company"), a biotechnology company developing immune cell therapies for the treatment of cancer,

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Gr …

Melbourne, Australia, 28 April 2023 - Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop A …

Melbourne, Victoria, Australia; 27 February 2023 Peter MacCallum Cancer Centre ("Peter Mac") and Cartherics Pty Ltd ("Cartherics") announced today they have entered into a Collaborative Development

Cartherics granted first patent in China for multiple development candidates

Melbourne, Australia, 09 January 2023 - Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop A …

Melbourne, Victoria, Australia; 08 November 2022: The Peter MacCallum Cancer Centre ("Peter Mac") and Cartherics Pty Ltd ("Cartherics") announced today they have entered into a

Go To Page: